Member Info for EmeraldCarrots

Tomo77.

You need to put some money in your account first.

Up 10.77%.

I'm not used to this.

And I sugggest everyone else here does the same. If no one replies to his posts he will eventually stop.

Moab.

Fair enough comment, Moab. However, if you have cancer that has, or may be spreading, and you want targeted treatment that needs a biomarker to home in on, I don't think you could do better than use Angle's dual analysis to look for one. That is my opinion as things stand. Angle's dual analysis for lung cancer has only been available from their services side for a few months. The only place in the World as far as we know. At minimum it is, or will be in Illumina's documentation. I suspect it will appear on their web site in due course.

All IMHO.

As this has been the normal way for decades. The traditional way. But they are out of date. By a week, weeks or even months. Circulating tumour DNA (CtDna) analysis can be up to date as it is done from a blood sample, possibly same day. Circulating tumour cell DNA analysis (CtC DNA analysis ) also comes from blood so can also be up to date. Who's to say the biomarkers obtained from the tissue sample are more accurate than ones obtained from a blood sample? Maybe blood analysis will one day render tissue analysis obsolete?

All IMHO....

Analysis results are not fiction. They are real and Angle Plc are the only Company in the World that offer this service. Uncontaminated live intact circulating tumour cells are needed and Parsortix is the machine you need. Now Myriad are on board the flood gates will open.

All IMHO.

Analysis results are not fiction. They are real and Angle Plc are the only Company in the World that offer this service. Uncontaminated live intact circulating tumour cells are needed and Parsortix is the machine you need. Now Myriad are on board the flood gates will open.

All IMHIO.

Confirmation of the first Scottish hospital installations.

Implemrntation guide recommends the CYP2C19-ID kit is rolled out to the entire NHS in the UK.

Confirmation the FDA application for the MT-RNR1 will go in before December.

This would be nice!

Her's hoping!!!!!!

1.5p plus here we come????

As this has been the normal way for decades. The traditional way. But they are out of date. By a week, weeks or even months. Circulating tumour DNA (CtDna) analysis can be up to date as it is done from a blood sample, possibly same day. Circulating tumour cell DNA analysis (CtC DNA analysis ) also comes from blood so can also be up to date. Who's to say the biomarkers obtained from the tissue sample are more accurate than ones obtained from a blood sample? Maybe blood analysis will one day render tissue analysis obsolete?

All IMHO.

Slacker246.

The Directors are not allowed to buy shares at the moment.

Absolutely huge multi-billion $ Companies. Whoever takes over as CEO will be in a good position as far as contacts at these massive Companies goes. It's a great shame he could not nail one or two mega deals. I suspect he got very close but the shareholders finally lost patience. Astrazeneca, Eisai, the NHS, Myriad Genetics, Illumina to name but a few. What he has lined up may still turn this all around.

All IMHO.

That you have made up is against the law in the uk. Also stating forward selling when you have, I assume, made that up too. Of course if you have not made it up it is insider trading and that is also totally illegal. All in all your post is totally illegal. I have reported you to LSE and if you persist I will report you to the FSA.

Standard CtDna does. This is key. Lung cancer now, other cancer tyoes to follow..

Dual analysis is the key, and only Angle's lab offers it anywhere in the World (only as of the last 3 months or so). OK it's only for lung cancer at the moment but it's a big World. Also the UK's NHS is considering a pilot study, I can't see than not happening myself. And it uses an Illumina assay panel. Some lung cancer drugs target certain biomarkers. If you want to find out if your lung cancer patient has these biomarkers, where do you send your blood sample for analysis? To Angle Plc because their dual analysis has twice the chance of finding the patients cancer has suitable biomarkers. Lung cancer is just the start. Remember this is WORLDWIDE.

https://webcast.openbriefing.com/angle-sept25/player/?player_id=57374

I'm happy to hold Angle Plc shares. The future is looking very very good.

Could take their CtDna analysis to a new level.

Note Grail are involved in the existing CtDna test so they will be aware Angle want to join in.......... Hmmmm..... Illumina's old pals.

"The NHS is now offering a circulating tumour DNA (ctDNA) blood test as part of a "blood test-first" approach for diagnosing suspected lung cancer in England, aiming to speed up the process to find out if patients are eligible for targeted therapies. This liquid biopsy, also known as a DNA blood test, detects tumour DNA in the blood, allowing for faster identification of the genetic mutations driving the cancer, potentially up to two weeks earlier than traditional tissue biopsies. While this test helps identify patients for tailored treatments and can spare some from unnecessary further tests, a tissue biopsy will still be required in most cases to confirm a diagnosis".

============

Angle want their "dual analysis" added to this. Should find about twice as many cancer biomarkrs as CtDna alone. They had meetings several weeks ago with NHS people.

All IMHO.

Analysis to the existing lung cancer CtDna analysis they now do. Based on the Illumina 79 gene lung cancer assay I presume that has already been developed to work with the parsortix system to get the dual analysis.

All IMHO.

Latino

"Agree it’s crazy and a no brainer…they have done all the research and have trialled with NHS and already spend 10s of Millions. Surely absolute bargain for anyone buying this down here…it’s mind baffling!

One thing for sure once ONE bid comes in it’s highly likely it will be a bidding war."

=======================

Agree. A sitting duck. It's truly unbelievable.

As the Directors last bought around the 2.2p mark (last December) a premium to that would be the minimum I think. 2.5p to 3.5p a share.

All IMHO.

Don't believe it. Are there no medical equipment suppliers that are interested? It is inconceivable to me. I really don't believe that is possible all things considered. Maybe they are in talks.

All IMHO.